Blood test predicts treatment response for metastatic prostate cancer
Testing could lead to extension of life through improved clinical decision-making by identifying patients who need to switch from targeted hormonal therapy to chemotherapy...
List view / Grid view
News
Higher rifampin doses for TB appear more effective with no greater risks
Higher daily doses of rifampin, a cornerstone of tuberculosis treatment, were shown to kill more TB bacteria in sputum cultures without increasing the adverse effects of treatment, according to a recent randomised controlled trial.
Immunotherapy drug could boost hormone treatment for prostate cancer
Researchers believe the combination with established treatment could improve outcomes in prostate cancer...
Rapid Zika detection test uses smartphone technology
Leveraging nanoparticles and digital health technology, BWH investigators develop rapid, deployable, low-cost diagnostic test for Zika virus
FDA approves Epidiolex derived from marijuana, for severe epilepsy
The FDA has approved Epidiolex oral solution for the treatment of seizures associated with two rare and severe forms of epilepsy...
Phenformin-mTOR inhibitor combination shows promise in HCC
A combination of mTOR inhibitors and Phenformin leads to an increase in overall survival...
bioMérieux launches ENDOZYME® II GO, an innovative test for the detection of endotoxins in pharmaceutical microbiology control
bioMérieux, a world leader in the field of industrial microbiological control, announces the launch of ENDOZYME® II GO, a new endotoxin test in the bioMérieux ENDONEXT™ range of recombinant horseshoe crab Factor C (rFC) assays.
Cannabinoid topical cream for treatment of Female Hypoactive Sexual Desire Disorder
Pivot Pharmaceuticals Inc. is to begin human clinical trials of PVT-005, the pharmaceutical drug candidate for the treatment of HSDD...
Micropacemaker demonstrates improved approach to heart pacing
Researchers at Children's Hospital Los Angeles and the University of Southern California have demonstrated the feasibility of implanting a micropacemaker system in the pericardial sac surrounding the heart – a breakthrough that may open up new cardiac pacing options for children and adults.
Flu’s response to Xofluza explored
Scientists are now investigating the Xofluza mode of action in detail and have uncovered possible mechanisms by which viral resistance to it could emerge...
Delivering insulin in a pill
Technique could replace daily injections for diabetics...
We met. We learnt. We discovered.
On Wednesday 23 May 2018, over 1200 scientists, technicians, speakers and exhibitors descended on the East Midlands Conference Centre at the University of Nottingham for the fifth Scientific Laboratory Show and Conference...
FDA approves the inclusion of new evidence for Cosentyx in PsA
The FDA has approved the inclusion of new evidence that Cosentyx significantly slows the progression of joint structural damage..
Scientists develop combined therapy for stroke victim recovery
Scientists in Switzerland have demonstrated that combining a brain-computer interface (BCI) with functional electrical stimulation (FES) can help stroke victims recover greater use of their paralysed limbs – even years after the stroke.
Repurposing cancer drugs may lead to a new approach to treating TB
Promising experimental cancer chemotherapy drugs may help knock out another life-threatening disease: tuberculosis (TB)...
